[1] Ganem D,Prince AM.Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med,2004,350:118-119. [2] Hepatitis B(Revised August 2008).World Health Organization, 2010-12-9. [3] Lu FM,Zhuang H. Management of hepatifis B in China. Chin Med J(Engl),2009,122:3-4. [4] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [5] 中华医学会传染病与寄生虫病学分会和肝病学分会.病毒性肝炎防治方案. 中华肝脏病杂志,2000,8(6):324-329. [6] 张建军,吴丽萍,杜瑞清,等. 慢性乙型肝炎患者肝组织病理学改变与血小板计数和血清肝纤维化指标的相关性研究. 实用肝脏病杂志,2013,15(3):226-228. [7] 章丽娟.肝硬化患者临床检验血清学指标检测分析. 中国医学统计,2013,20(2):97-99. [8] 张晶,宗春华,李定国,等. 肝内肾素-血管紧张素-醛固酮系统与大鼠肝纤维化的关系.世界华人消化杂志,2002,10:397-400. [9] Kumar R,Singh V P,Baker KM. The intracellular rennin- angiotensin system:a new paradigm. Trends Endocrinal Metab, 2007,18: 208-214. [10] Varo N,Iraburu MJ,Varela M,et a1.Chronic AT(1)blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension,2000,35(6):197-202. [11] Marshall RP,Mcanuily RJ,Laurent GJ. Angiotensin Ⅱ is mitogentic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care,2000,161:1999-2004. [12] Okada Q,Inoue T,Kanno Y,et al. Interstitial fibroblast-like cells expresses rennin-angiotensin system component in a fibrosing murine kidney. Am J Pathol,2002,160:765-772. [13] Bataller R,Sancho Bru P,Gines P,et a1. Activated human hepatic stellate cells express the rennin-angiotensin system and synthesize Angiotensin Ⅱ. Gastroenterology,2003,125(1):117-125. [14] 杨柳,刘海林. 血浆肾素、血管紧张素Ⅱ和醛固酮与肝纤维化关系的实验研究. 肝脏,2007,12(3):188-200. [15] 袁勇,朱洪. 乙型肝炎患者血清HA与Ang Ⅱ的相关性研究.重庆医学,2013,42(26):3120-3121. [16] Bataller R,Gines P,Nicolas JM,et a1.Angiotensin Ⅱ induces contraction and proliferation of human hepatic stellate cells.Gastroenterology,2000,l18:l149-1156. [17] 龚浩,王宇,张忠涛,等.血管紧张素lI及其受体拮抗剂对肝星状细胞收缩的影响.中华肝胆外科杂志,2006,10: 695-698. [18] Hidaka H,Kokubu S,Nakazawa T,et a1.New angiotensin Ⅱ type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis.Hepatol Res,2007,37(12):1011-1017. [19] 汤绍辉,张嫚嫚,吴小娟,等. 血管紧张素Ⅱ受体拮抗剂治疗肝硬化门静脉高压症疗效和安全性的荟萃分析.中华内科杂志,2011,50(12):1013-1018. [20] 李国云, 孟丽萍, 傅茂英, 等. 替米沙坦对肝纤维化大鼠肝组织病理学变化的影响. 实用肝脏病杂志,2011,14(3):173-175. |